Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Burden of Osteoarthritis in Iran: A National and Subnational Perspective, 1990−2019 Global Burden of Disease Study Publisher



Khadembashiri MA1 ; Khadembashiri MM1 ; Khonji MS1 ; Ahmadi M2 ; Mirdamadi N2 ; Ahadi T1 ; Raissi G1 ; Cham MB1, 3 ; Soleymanzadeh H4 ; Ansari H1 ; Forogh B1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Physical Medicine and Rehabilitation, Neuromusculoskeletal Research Center, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Student Scientific Research Committee, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Orthotics & Prosthetics, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Neuromusculoskeletal Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Health Science Reports Published:2025


Abstract

Background and Aims: Osteoarthritis (OA) is a chronic degenerative joint disease caused by pro-inflammatory factors and protease activity, leading to progressive joint destruction. The data on a global scale indicate a substantial rise in OA. This study evaluates the burden of OA in Iran, given its high impact and the limited number of epidemiological studies on the condition. Methods: The data pertaining to the prevalence, years lived with disability (YLD), and incidence and age-standardized rates of OA in Iran and its subnational regions were retrieved using the Global Burden of Disease Study (GBD) Results Tool. Results: Age-standardized prevalence rate (ASPR) of OA in Iran was 5224.14 (4699.54–5821.43) and 5588.22 (5041.17–6228.61) in 1990 and 2019, which was lower than the global level. The knee was the most prevalent OA in both 1990 and 2019 in Iran, 3326.63 (2862.19–3841.62) and 3660.61 (3151.81–4228.27) respectively, followed by hand OA (1432.43 (1078.03–1922.21) in 1990 and 1476.24 (1107.91–1979.80) in 2019) and hip OA (239.08 (184.05–300.68) in 1990 and 277.65 (213.24–351.43) in 2019). The age-standardized YLD rate of OA in Iran was 180.96 (91.76–355.00) in 1990 and 195.27 (98.67–381.01) in 2019. The age-standardized YLD rate of site-specific OA followed the same trend as ASPR. Tehran province, followed by Alborz and Yazd provinces, had the highest ASPR of OA in 1990. In 2019, Tehran province (6144.94 (5526.53–6862.14)) remained at the first rank, followed by Mazandaran (5536.591 (4974.13–6165.62)) and Alborz (5512.88 (4946.79–6138.54)) provinces. Our findings show that the OA incidence rate peaked in the 55–59 age group in both males and females in 1990 and 2019. Conclusion: Despite being lower than global averages, the prevalence, incidence, and YLD due to OA in Iran have significantly increased over the past three decades. This highlights the need for healthcare policymakers to implement comprehensive strategies to manage OA burden and costs. © 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.
Related Docs
View other Related Docs
1. Increasing Burden of Lower-Extremity Fractures in the Middle East and North Africa (Mena) a 30-Year Epidemiological Analysis, Journal of Bone and Joint Surgery (2024)
2. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
3. Regional Burden of Chronic Kidney Disease in North Africa and Middle East During 1990–2019; Results From Global Burden of Disease Study 2019, Frontiers in Public Health (2022)
4. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
5. The Burden of Neck Pain Among Adults Aged 70 Years and Older in Iran, 1990–2019, Health Science Reports (2023)
6. Burden of Knee Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Archives of Orthopaedic and Trauma Surgery (2023)
7. Increasing Burden of Hip Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Archives of Orthopaedic and Trauma Surgery (2023)
8. Global, Regional, and National Burden of Cancers Attributable to Excess Body Weight in 204 Countries and Territories, 1990 to 2019, Obesity (2022)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (34)
Farshad Farzadfar (32)
Other Related Docs
9. Patterns of General and Abdominal Obesity and Their Association With Hypertension Control in the Iranian Hypertensive Population: Insights From a Nationwide Study, BMC Public Health (2025)
10. Global, Regional, and National Burden of Respiratory Tract Cancers and Associated Risk Factors From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Respiratory Medicine (2021)
11. Burden of Hand Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Journal of Hand Surgery (2023)
12. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2021)
13. The Burden of Rheumatoid Arthritis and Low Back Pain in North Africa and Middle East From 1990 to 2019: Results From the Global Burden of Disease Study 2019, International Journal of Rheumatic Diseases (2023)
14. Quality of Care of Peptic Ulcer Disease Worldwide: A Systematic Analysis for the Global Burden of Disease Study 1990-2019, PLoS ONE (2022)
15. The Burden of Type 2 Diabetes Mellitus and Attributable Risk Factors in Iran, 1990–2019: Results From the Global Burden of Disease Study 2019, Iranian Journal of Public Health (2024)
16. Global, Regional and National Burden of Osteoarthritis 1990-2017: A Systematic Analysis of the Global Burden of Disease Study 2017, Annals of the Rheumatic Diseases (2020)
17. Age–Sex Differences in the Global Burden of Lower Respiratory Infections and Risk Factors, 1990–2019: Results From the Global Burden of Disease Study 2019, The Lancet Infectious Diseases (2022)
18. Burden of Disease Scenarios for 204 Countries and Territories, 2022–2050: A Forecasting Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
19. Particulate Matter Pollution Remains a Threat for Cardiovascular Health: Findings From the Global Burden of Disease 2019, Journal of the American Heart Association (2023)
20. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
21. Global, Regional, and National Burden of Migraine in 204 Countries and Territories, 1990 to 2019, Pain (2022)
22. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
23. Comparative Analysis of the Effectiveness of Intra- Articular Injection of Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: Results of an Open-Label Trial, Archives of Bone and Joint Surgery (2021)
24. Estimating Mortality and Disability in Peru Before the Covid-19 Pandemic: A Systematic Analysis From the Global Burden of the Disease Study 2019, Frontiers in Public Health (2023)
25. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
26. Epidemiology of Mental Health Disorders in the Citizens of Tehran: A Report From Tehran Cohort Study, BMC Psychiatry (2023)
27. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
28. Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans, Journal of Diabetes and Metabolic Disorders (2021)
29. Global, Regional, and National Burden of Allergic Disorders and Their Risk Factors in 204 Countries and Territories, From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Allergy: European Journal of Allergy and Clinical Immunology (2023)
30. Global Disease Burden Attributed to Low Physical Activity in 204 Countries and Territories From 1990 to 2019: Insights From the Global Burden of Disease 2019 Study, Biology of Sport (2023)
31. The State of Health in the European Union (Eu-27) in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, BMC Public Health (2024)
32. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019, Cancer Medicine (2023)
33. Burden of Chronic Obstructive Pulmonary Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019, The BMJ (2022)
34. Does the Duration of Antibiotic Treatment Following One-Stage Treatment of Infected Total Knee Arthroplasty Influence the Eradication Rate? a Systematic Review, Archives of Orthopaedic and Trauma Surgery (2025)
35. Burden of Ischemic and Hemorrhagic Stroke Across the Us From 1990 to 2019, JAMA Neurology (2024)
36. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
37. Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet (2024)
38. Global, Regional, and National Mortality Due to Unintentional Carbon Monoxide Poisoning, 2000–2021: Results From the Global Burden of Disease Study 2021, The Lancet Public Health (2023)
39. The Association Between Healthy Beverage Index and Psychological Disorders Among Overweight and Obese Women: A Cross-Sectional Study, BMC Women's Health (2022)
40. Burden of Tension-Type Headache in the Middle East and North Africa Region, 1990-2019, Journal of Headache and Pain (2022)
41. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
42. Measuring Routine Childhood Vaccination Coverage in 204 Countries and Territories, 1980–2019: A Systematic Analysis for the Global Burden of Disease Study 2020, Release 1, The Lancet (2021)
43. Adolescent Transport and Unintentional Injuries: A Systematic Analysis Using the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
44. The Unfinished Agenda of Communicable Diseases Among Children and Adolescents Before the Covid-19 Pandemic, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study 2019, The Lancet (2023)
45. Global, Regional, and National Burden of Cancers Attributable to Tobacco Smoking in 204 Countries and Territories, 1990–2019, Cancer Medicine (2022)
46. National and Subnational Burden of Stroke in Iran From 1990 to 2019, Annals of Clinical and Translational Neurology (2022)
47. Injury Burden in Individuals Aged 50 Years or Older in the Eastern Mediterranean Region, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2022)
48. Prevalence of Plasma Lipid Abnormalities and Associated Risk Factors Among Iranian Adults Based on the Findings From Steps Survey 2021, Scientific Reports (2023)
49. Inequalities in the Prevalence, Diagnosis Awareness, Treatment Coverage and Effective Control of Diabetes: A Small Area Estimation Analysis in Iran, BMC Endocrine Disorders (2023)
50. Global, Regional, and National Burden of Upper Respiratory Infections and Otitis Media, 1990–2021: A Systematic Analysis From the Global Burden of Disease Study 2021, The Lancet Infectious Diseases (2025)